06.07.2018 • NewsBrenntagElaine Burridge

Brenntag to buy Canada Colors and Chemicals

Brenntag to buy Canada Colors and Chemicals
Brenntag to buy Canada Colors and Chemicals

In its third acquisition so far this year, German distribution giant Brenntag has signed an agreement with Canada Colors and Chemicals (CCC) to acquire the Toronto company’s chemicals distribution business. Financial terms were not disclosed.

“With the acquisition of CCC, Brenntag strengthens its focus and specialties capabilities in both life science and material science. CCC’s broad positioning and extensive product and service portfolio perfectly complement Brenntag’s offer to our customers and suppliers,” said Brenntag Group’s CEO, Steven Holland.

Guy Carr-Harris, chairman and CEO of CCC, added that the combination of Brenntag’s global reach and the Canadian company’s technical capabilities provides a compelling platform for its customers and suppliers.

CCC operates several facilities across Canada that can store, blend and package industrial and specialty chemicals and products, serving industries including life sciences, water treatment, coatings, construction, energy and mining. Its life science business has an ingredients application laboratory and offers several of its own formulations.

Brenntag said CCC’s blending capabilities and formulation expertise in the oil & gas business opens “interesting” synergistic business opportunities with the German group’s oil & gas operations in Canada.

CCC generated sales of about EUR 140 million in fiscal 2017. The transaction is expected to close during the coming weeks, subject to the usual conditions.

In May, Brenntag completed its acquisition of Portugal’s Quimitecnica and gained a 65% stake in India’s Raj Petro Specialties. The Germany-based distributor will take the remaining 35% stake in the Indian petroleum products distributor after a period of five years.

Company

Logo:

Brenntag SE

Messeallee 11
45131 Essen
Germany

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read